Sandbox Reserved 712: Difference between revisions
| Line 53: | Line 53: | ||
[[Image: Structural_changes_in_PRdrv5_mutant.jpg|right|200px|thumb| Fig.3 Structural changes in PR<sub>DRV5</sub> mutant relative to wild-type PR <ref name="Molecular" />]] | [[Image: Structural_changes_in_PRdrv5_mutant.jpg|right|200px|thumb| Fig.3 Structural changes in PR<sub>DRV5</sub> mutant relative to wild-type PR <ref name="Molecular" />]] | ||
[[Image: Detailed_view_of_darunavir-enzyme_interactions.jpg|right|200px|thumb| Fig.4 Detailed view of the darunavir-enzyme interactions. <ref name="Molecular" />]] | [[Image: Detailed_view_of_darunavir-enzyme_interactions.jpg|right|200px|thumb| Fig.4 Detailed view of the darunavir-enzyme interactions. <ref name="Molecular" />]] | ||
The crystal structure was determined in complex with darunavir with 1.8-Å resolutions. The crystal formed | The crystal structure was determined in complex with darunavir with 1.8-Å resolutions. The crystal is formed out of one PR dimer in the asymmetric unit with two inhibitor molecules bound in alternative orientations. | ||
Surface residues <scene name='Sandbox_Reserved_712/R45/1'>R45</scene> and <scene name='Sandbox_Reserved_712/R55/1'>R55</scene> | Surface residues <scene name='Sandbox_Reserved_712/R45/1'>R45</scene> and <scene name='Sandbox_Reserved_712/R55/1'>R55</scene> have disordered side chains, but the other amino acid residue changes could be modeled into well-defined electron density maps. | ||
PR<sub>DRV5</sub> contains darunavir mutations V82T and I84V (see Fig.2, Part B, indicated in bold print) that are directly involved in substrate-darunavir-interactions (change of S2/S2' subsites). | PR<sub>DRV5</sub> contains darunavir mutations V82T and I84V (see Fig.2, Part B, indicated in bold print) that are directly involved in substrate-darunavir-interactions (change of S2/S2' subsites). | ||